LDN stands for low dose naltrexone, a repurposed version of a drug originally approved to treat opioid and alcohol addiction. At its standard dose of 50 mg, naltrexone blocks opioid receptors to reduce cravings. At much lower doses, typically between 0.5 mg and 4.5 mg, it appears to work through an entirely different mechanism: calming inflammation in the central nervous system. This off-label use has gained significant attention for managing chronic pain, autoimmune conditions, and other inflammatory disorders.
How LDN Differs From Standard Naltrexone
Standard naltrexone is FDA-approved at 50 mg for addiction treatment. It works by sitting on opioid receptors and preventing drugs or alcohol from activating them. LDN uses the same molecule but at roughly one-tenth the dose or less. At these tiny amounts, naltrexone doesn’t just block opioid receptors. It briefly occupies them, then falls off, which triggers the body to compensate by producing more of its own natural painkillers (endorphins). This “rebound” effect is one proposed reason LDN helps with pain and mood.
But the more compelling science points to a second mechanism entirely. At low doses, naltrexone appears to quiet a specific type of immune cell in the brain and spinal cord called microglia. When these cells become chronically overactivated, they pump out inflammatory chemicals that drive pain sensitivity, fatigue, brain fog, sleep disruption, and general malaise. LDN seems to shift these cells from an aggressive, inflammatory state into a calmer, anti-inflammatory one. Researchers have described it as one of the first medications to directly modulate these immune cells for chronic pain management.
What LDN Is Prescribed For
Because LDN targets central nervous system inflammation rather than a single disease, it’s used across a surprisingly wide range of conditions. The most common include fibromyalgia, chronic fatigue syndrome, multiple sclerosis, Crohn’s disease, complex regional pain syndrome, and other autoimmune or chronic pain disorders. More recently, some clinicians have prescribed it for long COVID symptoms, using a slow titration starting at 1 mg for the first month and increasing to 2 mg in the second month.
The common thread among these conditions is that they involve chronic, low-grade inflammation that standard treatments often fail to fully control. LDN isn’t targeting the pain signal itself the way a typical painkiller would. Instead, it’s addressing the underlying inflammatory process that makes the nervous system hypersensitive in the first place. This is why patients often report improvements not just in pain but in sleep quality, energy levels, and mental clarity.
Typical Dosing
Most providers start LDN at a low dose, often 0.5 mg or 1 mg, and gradually increase over weeks. The most commonly cited target dose is 4.5 mg per day, but observational research shows the effective dose varies widely from person to person. In one study, established doses ranged from 0.1 mg to 5.6 mg, with the majority of patients settling at 2 mg or less. The dose appears to be highly individual, meaning what works for one person may be too much or too little for another.
If side effects appear during the increase, the typical approach is to cut the dose in half for about a week, then try increasing again. Most people take LDN at bedtime, though some switch to morning dosing if sleep disturbances become an issue.
How Long It Takes to Work
LDN is not a fast-acting medication. Most patients don’t notice pain relief within the first few weeks. In a case series tracking chronic pain patients, 72% experienced their initial improvement somewhere between one and three months after starting. Another 12% didn’t see benefits until after three months of consistent use. This slow onset is important to know going in, because many people abandon the medication too early, assuming it isn’t working. Clinicians who prescribe LDN regularly advise completing at least a full prescription cycle before judging whether it’s effective.
Common Side Effects
LDN is generally well tolerated, especially compared to many conventional pain or autoimmune medications. The most frequently reported side effects are vivid dreams, mild headaches, and temporary sleep disturbances, particularly in the first few weeks. These tend to fade as the body adjusts. Some people experience mild nausea or irritability early on. Serious side effects are rare at these low doses, which is part of what makes LDN appealing for long-term use in chronic conditions.
A Critical Interaction With Opioid Medications
Because naltrexone blocks opioid receptors, combining LDN with opioid pain medications is risky. Most drug interaction tools flag this combination as a risk for opioid withdrawal, which is the expected concern. But at least one documented case revealed a more dangerous and unexpected reaction: a patient on LDN for multiple sclerosis received a single 5 mg dose of oxycodone and became deeply unresponsive, requiring emergency treatment and an overnight stay in intensive care. This suggests the interaction can go beyond simple withdrawal and cause a heightened, unpredictable sensitivity to opioids. If you take LDN, any provider prescribing you medication, including in emergency settings, needs to know.
How to Get LDN
LDN is not available as a standard pharmacy product. Because the FDA-approved naltrexone tablet comes in 50 mg, and LDN doses are a fraction of that, the medication must be prepared by a compounding pharmacy. These specialized pharmacies custom-make the capsules, tablets, or liquid formulations in the exact milligram dose your provider orders. This means you’ll need two things: a prescription from a provider willing to prescribe it off-label, and access to a compounding pharmacy that can fill it.
Not all physicians are familiar with LDN, so finding a prescriber sometimes requires looking for providers who specialize in chronic pain, integrative medicine, or the specific condition you’re managing. The cost varies but is often modest since naltrexone itself is a generic drug. Insurance coverage is inconsistent because LDN is an off-label, compounded medication, so many patients pay out of pocket.
The Evidence So Far
LDN sits in an unusual spot in medicine. It has a growing body of clinical evidence supporting its use, particularly for fibromyalgia and chronic pain, along with a strong safety profile and a plausible biological mechanism. Lab research has confirmed that at low concentrations, naltrexone shifts brain immune cells from an inflammatory to an anti-inflammatory state, and this aligns with what patients report clinically. However, large-scale randomized controlled trials, the gold standard for medical evidence, remain limited. Most of the published data comes from smaller studies, case series, and observational research.
Part of the reason for this gap is economic. Naltrexone is a decades-old generic drug, so no pharmaceutical company stands to profit from funding expensive trials for an off-patent medication at unconventional doses. This hasn’t stopped clinical adoption. Prescribing has grown steadily, driven largely by patient advocacy and clinicians who’ve seen results in practice. The mechanism is real, the side effect profile is favorable, and the early clinical data is promising, but anyone considering LDN should understand that the evidence base is still catching up to the enthusiasm.